Clopidogrel is an antagonist of irreversible inhibition formed by covalent binding of cysteine residues of P2Y12 receptor. It is a routine drug for anti platelet aggregation treatment after PCI
Clopidogrel is an antagonist of irreversible inhibition formed by covalent bonding of cysteine residues of P2Y12 receptor, and it is a routine drug for anti-platelet aggregation therapy after PCI.